Clinical trial

Nationwide Research on the Rewilding of Kindergarten Yards - Vahvistu

Name
R24023
Description
Biodiversity is essential for nature and human well-being. Land use has reduced biodiversity in cities that is associated with altered commensal microbiota and a rising burden of immunological disorders among urban children. The investigators will estimate how rewilding of kindergarten yards affects commensal microbiome, prevalence of allergies, asthma, atopic dermatitis and infections, cortisol levels, cognitive skills and plasma cytokine levels of children. Our specific aims are: To assess if rewilding diversifies health-associated skin, saliva and gut microbiota and reduces infectious diseases and atopic or allergic symptoms. Assess whether the rewilding has positive effects on cognitive skills. Assess whether the rewilding changes cortisol and plasma cytokine levels. The investigators will recruit altogether 320 (160 per treatment) study subjects aged between 1-5 to questionnaire study (Task 2), from which 120 study subjects will be analyzed more detailed using microbiological and blood samples (Task 1).
Trial arms
Trial start
2024-05-01
Estimated PCD
2027-08-30
Trial end
2027-08-30
Status
Recruiting
Treatment
Biodiversity
In rewilding kindergartens, the yards are modified with biological elements, i.e., vegetation and plantation will be added to the yards.
Arms:
Rewilding
Playground equipment
Playground equipment that increase the physical activity of children will be added to the kindergarten yards.
Arms:
Control
Size
320
Primary endpoint
Skin Gammaproteobacteria
Baseline, 3 month, 1 year, 2 year, 3 year
Eligibility criteria
Inclusion Criteria: * Attendance in kindergarten Exclusion Criteria: * Use of antibiotics in the year before sampling
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'NON_RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'PREVENTION', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 320, 'type': 'ESTIMATED'}}
Updated at
2024-04-30

1 organization

1 product

8 indications

Indication
Allergy
Indication
Nature
Indication
Human